New Clinical Practice Guidelines, September 2017

John Anello; Brian Feinberg; Richard Lindsey; Cristina Wojdylo; Olivia Wong, DO; Yonah Korngold; John Heinegg. Sam Shlomo Spaeth


September 15, 2017

In This Article

Peripheral Arterial Disease

Guidelines on peripheral arterial disease by the European Society of Cardiology[3]

  • Smoking cessation is recommended in all patients with peripheral arterial disease (PAD).

  • Healthy diet and physical activity are recommended for all patients with PAD.

  • Statins are recommended in all patients with PAD.

  • In patients with PAD, it is recommended to reduce LDL-C to <1.8 mmol/L (70 mg/dL) or decrease it by ≥50% if baseline values are 1.8–3.5 mmol/L (70–135 mg/dL).

  • In diabetic patients with PAD, strict glycemic control is recommended.

  • Antiplatelet therapy is recommended in patients with symptomatic PAD.

  • In patients with PAD and hypertension, it is recommended to control blood pressure at <140/90 mm Hg.

  • Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs) should be considered as first-line therapy in patients with PAD and hypertension.

For further reading, see Peripheral Arterial Occlusive Disease